BLGO

MarmotsRMtnGophers

BLGO commercialization of Clyra.

julian_jakobi

Historically they did best when they leave the selling of their amazing tech to partners. POOPH became a blockbuster success. (before their partner stopped paying). Now they have partnered with a Global leader in clean water tech - AQUATECH that installed thousands of water systems in 60 different countries. They are implementing BLGO PFAS remediation tech into their huge water systems- 7 Bids are out already. Clyra Medical partnered with Al -Hikma the leading medical distribution company in the Middle East. Additionally one of the global top 4 medical companies will release a cobranded product at scale later this year. The engineers just signed a $1.2 Million contract - they almost doubled revenues last year and will likely double this year also. A relaunch of a Pet product seems likely in 2026 also. I am a long term investor and all of the above are things I was waiting for for years. Obviously others lost their patience. BUT I am 100% confident this longterm investment will reward all shareholders plenty. We know what is coming and at a $35 million market cap A LOT of money can be made IMHO 😉 mom and dad companies run out of a garage without any revenue have a higher market cap than that. The reevaluation will be pretty and we know it will happen. Best of luck! Do your Own DD!

LostAbbott

Today had a stupid amount of volume.  We had a similar dip a week or so ago?  I don't know what is going on, but either someone lost patience with the. Company or shorts have started to think the cellar is a good place for Dennis...   I don't know that adding here is the play or just holding to see if we go to .08.  I am average around .16 and could see doubling down at .08 or below...  I have been into BLGO for half a decade at this point.  It always had had a lot of promise paired with failure to launch and over promises...

julian_jakobi

BioLargo Signs Deal To Accelerate Commercialization Of PFAS Treatment Technology **Strategic Partnership Aims to Scale Advanced “Forever Chemicals” Remediation Solutions for Safer Water and Environmental Protection.** By Henry DeVries, Senior Writer, California Business Journal Southern California cleantech company BioLargo and global water purification company Aquatech are collaborating to enable the deployment of technology as a concentration and collection step within Aquatech’s full flowsheet solutions for PFAS treatment, including destruction. “By partnering with Aquatech – one of the most respected and capable organizations in the global water treatment industry – we can significantly amplify the reach and impact of our Aqueous Electrostatic Concentrator technology,” said Tonya Chandler, president of BioLargo Equipment. “Together, we are combining proven engineering, innovative science, and deep market experience to deliver scalable PFAS treatment solutions for industrial, municipal, and government clients.” BioLargo Equipment is a subsidiary of BioLargo, Inc. (OTCQX:BLGO), an environmental engineering company developing and commercializing sustainable technologies, announced it has signed into a memorandum of understanding (MOU) with Aquatech to advance the integration and commercialization of BioLargo’s proprietary Aqueous Electrostatic Concentrator (AEC) for PFAS treatment. BioLargo’s AEC technology is designed to remove per- and polyfluoroalkyl substances (PFAS) from liquid streams, producing treated water suitable for drinking water applications. AEC uses electromotive force to collect and immobilize PFAS directly onto membrane surfaces without generating a secondary concentrated liquid waste stream. This collaboration enhances the two companies’ ability to integrate AEC with Aquatech’s comprehensive, end-to-end PFAS treatment solutions that enable their public and private sector clients to meet evolving regulatory requirements. Aquatech is globally recognized for its technical excellence and innovation in sustainable water and wastewater management and was awarded *Water Technology Company of the Year* at the 2025 Global Water Summit in Paris, France. Aquatech’s industry-leading technology portfolio includes membrane, thermal, biological, electrochemical and ultrapure water treatment solutions. The agreement establishes a non-exclusive framework for collaboration on PFAS treatment projects worldwide, enabling both companies to combine their complementary technologies to better serve the rapidly growing PFAS remediation market. Aquatech International’s corporate headquarters is located in Canonsburg, Pennsylvania, Established in 1981, the company is a global leader in water purification technology for industrial and infrastructure markets, specializing in desalination, water reuse, and zero liquid discharge. “Coupling BioLargo’s AEC PFAS collection and concentration technology with Aquatech’s PFAS removal and destruction expertise presents a powerful opportunity to fast-track effective solutions to serve the customer,” said Devesh Mittal, vice president of Aquatech Environmental Services. *Henry DeVries is a former Forbes online columnist who is the chief book strategist at Indie Books International. He has ghostwritten, co-authored, or edited more than 200 business books, including his international bestseller*, How to Close a Deal Like Warren Buffett*.* *https://calbizjournal.com/biolargo-signs-deal-to-accelerate-commercialization-of-pfas-treatment-technology/*

SpaceMurse

BLGO pamping! Good company too

julian_jakobi

$BLGO the progress is real and not reflected in the price at all: ✅ Lake Stockholm AEC install - done. January 27, 2026. Live. In the ground. Under NJDEP & EPA monitoring. First real-world municipal PFAS deployment. ✅ Clyra first stocking order - secured February 2026 through Advanced Solution’s national US distribution network. Hospitals. Clinics. Revenue starting. ✅ Clyra Al Hikma deal - signed May 5, 2026. Exclusive Middle East + North Africa distribution for ViaCLYR™. GCC, Levant, and adjacent markets. ✅ $1.2M Minerals Contract signed - April 20, 2026 BioLargo Engineering providing its expertise in designing and engineering the pilot-scale facility. ✅ New MOU signed - May 3, 2026. Another AEC partnership in motion (Aquatech) That’s five material updates in roughly 100 days. No guts - No Glory💪🏻 📈

julian_jakobi

$BLGO the progress is real and not reflected in the price at all: ✅ Lake Stockholm AEC install - done. January 27, 2026. Live. In the ground. Under NJDEP & EPA monitoring. First real-world municipal PFAS deployment. ✅ Clyra first stocking order - secured February 2026 through Advanced Solution’s national US distribution network. Hospitals. Clinics. Revenue starting. ✅ Clyra Al Hikma deal - signed May 5, 2026. Exclusive Middle East + North Africa distribution for ViaCLYR™. GCC, Levant, and adjacent markets. ✅ $1.2M Minerals Contract signed - April 20, 2026 BioLargo Engineering providing its expertise in designing and engineering the pilot-scale facility. ✅ New MOU signed - May 3, 2026. Another AEC partnership in motion (Aquatech) That’s five material updates in roughly 100 days. No guts - No Glory💪🏻 📈

julian_jakobi

$BLGO important nuance: Aquatech isn’t just “some partner.” They claim 2,000+ global installations and 1.6B+ gallons treated daily across water systems. Their PFAS full-flowsheet/destruction offering appears custom/project-based, not a mass-produced unit line, but that’s exactly why BLGO’s AEC could matter as a concentration step inside bigger PFAS treatment trains. Big commercialization door opening!!

julian_jakobi

$BLGO important nuance: Aquatech isn’t just “some partner.” They claim 2,000+ global installations and 1.6B+ gallons treated daily across water systems. Their PFAS full-flowsheet/destruction offering appears custom/project-based, not a mass-produced unit line, but that’s exactly why BLGO’s AEC could matter as a concentration step inside bigger PFAS treatment trains. Big commercialization door opening.

julian_jakobi

$BLGO while I was drafting my DD MASSIVE NEWS came in. BioLargo signs MOU with Aquatech to accelerate commercialization of its AEC PFAS treatment technology. This is exactly the kind of validation longs have been waiting for: Aquatech brings global water treatment reach, engineering depth, and PFAS destruction expertise. BLGO brings AEC, a concentration/collection tech designed to remove PFAS without creating a secondary liquid waste stream. Industrial, municipal, government clients. Worldwide PFAS projects. Major commercialization pathway forming. This looks like a very serious step toward scale. This won’t stay a $50 million penny stock for much longer ;) do your own DD! MAximum Bullish. https://www.newswire.com/news/biolargo-signs-memorandum-of-understanding-with-aquatech-to-accelerate

julian_jakobi

Actually one of the multi million shares Biolargo holders points that out all the time. That SCWO has no revenues, only has one solution - that can't even compete with BioLargos tech. Yet they do have a similar market cap to BioLargo, that has revenues, already a commercial municipal installation and multiple best in class solutions in trillion dollar markets.. a massive case for the absurd undervaluation of BLGO.

julian_jakobi

It was only one. Years ago, I loaded up on $EXAS on a dip to $5 - a move that felt uncomfortable at the time but proved to be the right call. My remaining 400 shares were automatically sold a few weeks ago at $105 when the company was acquired. That same gut feeling? I’m getting it now with $BLGO. The current market pricing simply doesn’t reflect what’s happening inside this company. I’m rolling those gains straight into BioLargo - full conviction that higher levels are ahead.

broccoli0302

TLDR: I think things get interesting in about a year. Don’t take my word for it, go check out the filings and news reports about Clyra, AEC, Cupridyne Clean, BLEST, and Biolargo’s battery tech. Let me start by being very clear that I am just some dude and I do not have a background in any of the tech fields that Biolargo is working in. In other words, my answer to your question is based on generalist knowledge that could be very wrong based on not knowing medical supply timelines, etc. That being said, I’m invested and expect a timeline that looks something like below. This quarter is more or less a wash. There will be underwhelming revenue from Clyra because they are JUST getting started and trying to grow market adoption. The AEC in Lake Stockholm won’t do much for revenue either, so I think we’ll still see a net loss of a pretty wide margin as intense cash burn of “go to market” expenditures starts to taper off and revenue hasn’t quite caught up. I see this as the final dilution window where that $10 million stock offer option keeps them going. Next quarter should see Clyra start to come into its own. Their first product, Viaclyr, should see increasing revenue over time for the next several years because it is 1) an amazing product that revolutionizes wound care (not an exaggeration, read what the experts who tried it said) and 2) working its way into markets through sound technical channels. Their second product that they have a “gorilla” partner working on with them is likely to hit either in this or the next quarter given the releases we’ve seen about it. When that happens, we will see real revenue growth. I’ve watched interviews of the Clyra CEO and they have way more than two products in the pipeline so we should see some steady growth from about 2 quarters in the future to about the next 5-10 years without doing anything more than refining production lines. The AEC water treatment system in Lake Stockholm is undergoing a one year performance review by every agency you can think of at federal, state and local levels. The tech is good and should pass with flying colors, they’ve already demonstrated it for years now. Once it is officially field proven, it’s the only thing out there that currently meets FDA PFAS removal requirements. What do I think that means? Not much this year besides whatever the contract with the Lake Stockholm municipality pays, but a potential hockey stick type action following. Basically a near certain 10ish month catalyst. Pair those two catalysts and I think we are going to see the stock trade sideways for about the next two quarters before slowly climbing to about the .18 mark by end of year and then probably taking off about 12 months from now. There are a bunch of other X factors from Cupridyne Clean, the battery play, and their Engineering support contracts, but I am more confident about Clyra and AEC. I will close by saying that I am literally just some dude who reads fanatically about BLGO in his free time but has no expertise in any of this. Do not make a decision based on what I’m saying here. If you think this makes sense, go and read the filing from the company and the press reports about the various products and decide for yourself if I’m off base or on target.

ThrowRA91041

The BLGO shill is back! I bet those bags are heavy.

julian_jakobi

I like the way you’re thinking about focus - it’s exactly the right concern to have with any “platform” story. The key for me is that BioLargo isn’t one small team trying to juggle five ideas at once. It’s a holding company structure with separate, dedicated teams and their own CEOs for the big verticals: PFAS, Clyra Medical, Cellinity, and the engineering group. The core BLGO leadership allocates capital and sets strategy, but execution is pushed down to world‑class operators in each lane, not run out of one overcrowded inbox. So instead of one management team being “spread thin,” you effectively get multiple focused companies under one cheap ticker – each run by people whose full‑time job is to make that vertical work. That structure is exactly why I’m comfortable owning \~1.25% and still adding, rather than worrying they’re trying to do everything with one small generalist team. Each subsidiary has their own website - just check out the team behind Clyra for example: [https://www.clyramedical.com/our-team](https://www.clyramedical.com/our-team) please feel free to ask further questions. - It is so much happening at BioLargo that it is actually fun digging ;)

dbixon

BLGO is a penny-stock that could 50x in the next 3 years *if* any of their technologies get picked up in the marketplace. They’re basically an incubator with four ideas currently being fleshed out. The ideas are: forever-chemical filtration, liquid batteries for long term energy storage, next-gen surgical wound care, and an odor-elimination formula.

LostAbbott

Check out BLGO.  There are a lot of players in the clean water and more importantly PFAS game.  As far as I can tell BLGO likely has the best scale solution at a cheaper price point with less consumables...

Hamzehaq7

man, it's wild how undervalued BLGO seems right now. with all that tech and potential, $55M market cap feels like a joke. like, they've got legit advancements in PFAS removal and wound care that could change the game, but the price isn’t reflecting any of that. maybe the market’s just slow to catch up? idk... but with all those catalysts coming, it could turn around pretty quickly. i'm curious to see how the wound care stuff plays out, especially if it gets more attention. what’s your take on the timeline for those catalysts to kick in?

julian_jakobi

Thanks for the feedback. We have certainly seen higher levels before.. FYI: BioLargo (BLGO) technicals: after a long correction and consolidation, the chart shows a higher low and a tightening triangle, with selling pressure easing and volume stabilizing. First upside target \~0.25, then 0.40 and 0.60 if it breaks out with conviction; downside now looks relatively limited versus upside if commercialization catalysts hit. Do your own DD! https://preview.redd.it/x8nviag2kzpg1.jpeg?width=925&format=pjpg&auto=webp&s=487db15191b497e35bcf7872e7817e608e9473b2

GettinFroggyHere

Check out BioLargo (BLGO). It hasn't done .uch in the last couple of years but they are commissioning their first PFAS system install in NY state, cellinity grid-scale batteries, and just released a medical line up of products such as bandages and wound flush for hospitals. I have no hopes of immediate moon shots, but they seem to be on the cusp of making a ton of money. Their strategy is very investor concious, meaning they want to avoid dilution as part of their plan to scale up. I don't know if that will harm their ability to rapidly scale or not, as they have some creative paths to scale already in the works.

broccoli0302

Biolargo, BLGO. It has been sitting at .18 for months now. Biotech company that does odor removal, best in class PFAS removal, batteries and breakthrough wound care product. People are sleeping on it because of a “go to market” hiccup for their first product that they rolled out under odor control “Pooph” which has been a blocked punt. In the last 60 days they have just brought their PFAS and wound care products to market- first PFAS install in New Jersey and first stocking order for wound care products announced. Market cap at 55 million, both products are potential 3-4X catalysts IMO.

Get_rch_or_try_dyin

They weren’t getting paid . BLGO had to sue and pull their product back

Get_rch_or_try_dyin

Unfortunately the $3mil wouldn’t do much . I love Pooph, and I buy some every time I stop in petsmart. But BLGO really needs to get moving on stuff . I know the Clyra deal was unfortunate. But these guys have been operating for 35 years . At some point you have to get things done, or try something else . I’m rooting for these guys, and I’ve got a friend with a very significant amount of shares , but he’s been holding for like 7+ years now , and nothing has happened.

julian_jakobi

$BLGO step by step. 🚀 [https://www.linkedin.com/posts/dennispcalvert\_leachate-landfill-activity-7431724632354848769-HVLV?utm\_medium=ios\_app&rcm=ACoAAAdd6oMBHkrJzINwZ-5z-8ZtNA8QidL3Aqs&utm\_source=social\_share\_send&utm\_campaign=copy\_link](https://www.linkedin.com/posts/dennispcalvert_leachate-landfill-activity-7431724632354848769-HVLV?utm_medium=ios_app&rcm=ACoAAAdd6oMBHkrJzINwZ-5z-8ZtNA8QidL3Aqs&utm_source=social_share_send&utm_campaign=copy_link) Jul 23, 2025 · Project to develop a leachate treatment system for a client has progressed from bench-scale studies to plans for an on-site pilot, potentially leading to a $3 million full-scale system. “BioLargo has been awarded an additional phase to manufacture and run a pilot scale system onsite for a leachate pretreatment system. This initiative aims to address issues with leachate affecting the UV disinfection system at a local wastewater treatment facility. The company has successfully completed bench-scale testing to enhance transmissivity and is now ready to implement the pilot scale project in Florida.” Also regarding the Clyra launch. We know it’s coming - with a above 100 Billion $ market cap gorilla partner. Do your own DD. This won’t be a below $200 million company for very much longer IMHO. https://preview.redd.it/m1r5ue2uabmg1.jpeg?width=1290&format=pjpg&auto=webp&s=af7433e4cf6f3ca1026cdb245f7e1f094e92a8f2

Get_rch_or_try_dyin

When are they going to grow the business, grow revenue , get contracts , and return value to shareholders ? I think they have a ton of potential. But they need to get something to market or make some money soon. I’m fan and supporter of BLGO. But they need to make something happen soon

julian_jakobi

Great questions. I recommend that you spend the time to dig into it. $BLGO It is about education and patience - a lot of people are still on the sidelines, and as execution and commercialization progress become more visible, the market’s reevaluation could be substantial. Management believes the company is already trading at roughly 3–4x below where it should be and recently raised several million dollars at about this same valuation, which reinforces that view. Best of luck with your investing. https://youtu.be/9mdumBTDCac

julian_jakobi

$BLGO well observed. The progress is real. From simplywallstreet that featured BLGO as one of their favorite picks a couple of days ago: https://preview.redd.it/u5t3rm5w3ybg1.jpeg?width=1290&format=pjpg&auto=webp&s=77e419191675f71282da9e1798d227f0185c5d35

julian_jakobi

They mostly dilute only on the subsidiary level. Clyra revenue are expected to validate a market cap of north of $500 million within 18months. Their cash burn rate is really low. https://preview.redd.it/wug835ag2ybg1.jpeg?width=1227&format=pjpg&auto=webp&s=198fe099eb174d3e23254bacb246cb0f92bb5666 Note that management thinks they should be worth $200 million already. And projected future value is 50-87 x current market cap. The CEO recently addressed everything in a letter to shareholders: [https://feeds.issuerdirect.com/news-release.html?newsid=7448032311850076&symbol=BLGO](https://feeds.issuerdirect.com/news-release.html?newsid=7448032311850076&symbol=BLGO)

julian_jakobi

$BLGO It is about education and patience - a lot of people are still on the sidelines, and as execution and commercialization progress become more visible, the market’s reevaluation could be substantial. Management believes the company is already trading at roughly 3–4x below where it should be and recently raised several million dollars at about this same valuation, which reinforces that view. Best of luck with your investing. https://youtu.be/9mdumBTDCac

dbixon

BLGO has a new wound care solution coming out in partnership with a mega distributor in Q2. Should take the SP from 0.18 to >0.50.

dbixon

BLGO currently 0.18, I expect it over $1, by this time next year.

BlackMaelstrom1

Hurt me again, BLGO.

Get_rch_or_try_dyin

BLGO has massive potential

TheDeHymenizer

BLGO -50% Used to be GORO was down 80% at one point but am now break even and am expecting it to be my best investment ever if I'm reading recent releases correctly.

Own_Lynx_7265

Watching retail flow this morning and it’s a funny combo: **Bullish** * **$BLGO** – PFAS treatment play getting real industry love (AEC). Tiny name, big narrative. * **$ISSC** – literally trading like nobody noticed 20% ROIC + 27% growth. Discounted because it’s boring. * **$SEZL** – officially added to the S&P SmallCap 600. When funds *have* to buy, they buy. * **$NVDA** – China H200 shipments confirmed (again). Data center demand doesn’t care about TikTok bans. **Bearish** * **$PEP** – activist pressure to cut prices. Good for consumers, bad for margins. Pepsi might get “Ozempic’d.” **Neutral (eyes-on)** * **$SPY** – everyone waiting for NFIB + JOLTS + FOMC tomorrow. Market’s on mute mode until data hits. * **$AMD** – still in “regulatory rumor jail” thanks to the NVDA China mess. Could snap either direction depending on clarity.

julian_jakobi

Thanks for letting us know. Maybe, when I’ll get my 3 - 5X untill next summer with BLGO I will diversify a little bit ;)

dbixon

BLGO An incubator with a market cap only $50M. They have new technology approaching commercialization in three distinct fields: long term grid-level energy storage (liquid sodium batteries), forever-chemical filtration of water, and wound care. The wound care solution is launching commercially with a major international distributor in Q2’26. Estimated value of that launch is half a billion, and BioLargo owns 48% (5x current market cap). The forever-chemical filtration system is being installed this very second at its first commercial buyer location (a muni in New Jersey). The EPA is monitoring this as a pilot project. If successful, growth could be pretty rapid as everyone will want to advertise their new PFAS-free water (5x current market cap). Their battery (Cellinity) just passed 3rd party validation and offers significant benefits over current market options (doesn’t catch on fire among other things). Company is actively seeking a partner to build factories; 11 MOU’s signed as of last month. If successful, growth could be pretty rapid as AI energy demands continue (10x current market cap). Currently at $0.18/shr, 52wk low is $0.14 and high is $0.32. With their wound care launch right around the corner, this is an easy one to toss some speculation money at.

LostAbbott

Still just you and me.  I don't know what the deal is with BLGO.  I keep adding at .15ish, but man they just cannot excite.  The earnings call last week was more of the same Calvert always has lots of positive forward looking things to say, but nothing ever comes of it and they cannot exicute on what should be basic things.  POOPH was nothing but fairly weak excuses and "go read the lawsuit".  Yes Clyra sounds game changing, but so do the batteries and the PFAS, the just cannot get things to market and when they do some negative shit happens.  You can just chalk it up to a small company running into typical road blocks, but when you have been with these guys for nearly 5 years the same story over and over again is getting hard to keep buying... 100k, ~.19

stumblios

BLGO has been floating around this sub for at least 5 years now. It always has a story about how "it's finally about to execute the mission!" I've bought into it a couple times. I think I sold once for a mild profit and once for a mild loss. Is this the time that it finally takes off? Maybe, anything is possible. Or this could be another rinse + repeat. I will say, at the very least, you probably won't lose your shirt on this stock. I do believe it's the most stable penny stock I've ever seen. It's been trading between 10-40 cents for at least 7 years. 99% of tickers mentioned in this sub have gone through 3+ reverse splits in that time.

robbur88

This is true. That's why I didn't ask about the other 30 tickers that got spammed to me. I only click the ones with 20+ comments and those tend to be the ones that run. So I looked into BLGO enough that I think I need to return to DD on it later. But was hoping someone would throw a red flag and turn me away.

robbur88

So my feed page always has these randoms. I always assumed they were sponsored bot type stuff. But I started noticing that an odd amount of them getting spammed on runs just days later in here. Anybody looked into BLGO?

sexdick420

Why the long disconnect between FDA approval and product launch? It should have also been worth noting in your DD that Clyra isn’t fully owned by BLGO so what is the profit/revenue split going to look like? Especially since they are now adding a THIRD partner.

LostAbbott

I am not quite on your level of BLGO fandom, but I am still more than most.  I like these guys a lot.  However, the is chart is very crazy.  The number of "ifs" that need to hit for this to be real is pretty crazy...

pigeon_shit

BLGO has leading tech in PFAS removal. They have wear many hats and are way undervalued. Their earnings are also this week.

LostAbbott

Yeah I have a few different PFAS investments.  I like BLGO the best so far, but their process sounds interesting.  I know quite a few folks in Waste Water management and I am skeptical about how they "destroy the PFAS". None of that matters with a reverse splits.  Current shareholder always get wiped out with reverse splits.  Get out and wait for the split to bottom before you get back in.

travis2886

BLGO

travis2886

BLGO

julian_jakobi

Great to hear that you bookmarked it with a some shares. That is a good timeline. Hopefully at that point BLGO will be a multibillion Nasdaq traded powerhouse and I will own an island 🏝️🙋🏼‍♂️😉

RJM145

On paper and in theory I think you’re right and I know that “past performance is not an indicator of future…”. I continue to watch and you’ve given a fair timeline. My thought is about the opportunity cost of waiting for next year as it’s not going to have a UAMY style run up. Therefore, I’ll follow the news and possibly get back in before profitability is announced.  That said, now you got me worried I’ll be missing the boat haha.  I do believe in the company, the leadership and the technology. I’ve literally sat at a Starbucks with the founder/CEO in the early days and he’s as quality of a guy as I’ve met in business.  On a separate note, I’m mostly in mining stocks at this point, majority of which are penny and nearly all have either “silver” or “gold” in the name. So, with many late to that party, I think it has more movement before companies like BLGO, and my hope is to roll profits next year. 

stumblios

Yup, been reading about it being BLGO's time for almost 5 years now. I think it's the most stable penny stock I've ever seen.

dbixon

BLGO is about as low as it’s ever been, and their subsidiary Clyra is gearing up to launch (by next summer) a new product with a major distributor. Hope to see a nice pop by then. They have other pokers in the fire as well but this is the closest to generating substantial revenue in the near-ish term.

julian_jakobi

BLGO as much as I can get at these crazy discounted levels.

julian_jakobi

Look into $BLGO - the deeper you dive the more you will like it!

julian_jakobi

The Pooph licensing saga is a striking validation of BioLargo’s technology—CupriDyne enabled Pooph to achieve blockbuster success and a $50 million run rate in the pet odor market before licensing issues emerged. When Pooph tried to expand beyond its agreed territory and defaulted on payments, BioLargo decisively reclaimed its IP, showing strong management and commitment to shareholder protection. Pooph’s attempts to use BioLargo’s formula (improved formula with the same claims) outside their license will likely result in expensive legal consequences, but the key takeaway is how the tech proved itself in real consumer markets and is now ready for a better, more reliable partner. The revenue will be missed - but last Q it was only 40% of BLGO's revenue - so it was dwindling down already . It certainly was a reason why there was additional pressure on price but that offers an opportunity to add until the obove describd catalysts will become more visible and the upcoming Clyra launch will dwarf the Pooph revenues at peak anyhow.

Gydvinn

You are deeply mistaken. SCWO isn't meant to replace filtration at the front end of drinking water treatment. 374Water’s SCWO units are primarily aimed at: Military and DoD hazardous waste (AFFF foam, munitions cleanup), industrial waste streams, sludge from wastewater treatment , leachate from landfills. SCWO uses energy, but it is often self-sustaining after startup (organics provide thermal energy). SCWO isn’t for swimming pools that BLGO is interested in, it is for toxic sludge, leachate, AFFF waste, and what BLGO can’t handle.

julian_jakobi

Thanks for making the bullish case for BioLargo tech. Pfas is measured in parts per trillion - that means a grain of salt in multiple olympic sized swimming pools. So why would you treat all those swimming pools with A HIGH ENERGY destruction their tech when you could just use a tlow energy tech to collect the Pfas and then use a super oxidation tech to destroy the highly concentrated PFAS. (BLGO has their own tech for that as well). again, would you boil multiple swimming pools just to kill a some tiny "pollutants" - or wouldn't it make more sense to capture those pollutants first and then destruct them?

Gydvinn

Removing PFAS from water is one thing, but the challenge is how you deal with the concentrated PFAS (waste stream, disposal, destruction). SCWO’s claim is that it destroys organic / hazardous compounds (including PFAS) under extreme conditions (supercritical). That’s a different value proposition. So BLGO would need to not just remove PFAS, but responsibly handle or destroy it to fully compete. Aside from that, we first bought the rumor for SCWO. News are coming either today or early next week.

julian_jakobi

You are welcome. Biolargo - $BLGO

TheDeHymenizer

ooohhh another PFAS penny stock - might be a good hedge to my BLGO lol

dbixon

BLGO has a medium term catalyst with their BioClynse wound solution launching in Q1, and their Cellinity energy storage battery tech is a long term play. They’re also focusing on forever chemical water filtration (first project set to go live next week). I’m holding for a double up by summer.

julian_jakobi

I am 95 % in BioLargo. Shifted massive gains between 1200%- 2500% from $exas to $BLGO Accumulated 1.25% of a penny stock company that has yet to explode to the upside. Anything below 20x returns would be a disappointment. But for now an index fund would have been a better investment - but that was the case as well with EXAS - for years - before that started running. BLGO lift off seems very close and with such a commitment it could become life changing gains. Still hold 400 EXaS shares with $5 average.

TheDeHymenizer

Almost guaranteed 3x-4x - ELTP, SEUSF Outside shot 10x+ - GORO, BLGO, NLST

Get_rch_or_try_dyin

One of my friends has a few million shares of BLGO. I use their pooph products almost daily

Get_rch_or_try_dyin

BLGO definitely has huge potential! Wish you could buy it on Rh though. This one will make millionaires

dbixon

BLGO This won’t win your game, but if you’re looking for something to park some money in that could pop in the next 6-12 months thanks to a commercialization launch, it’s a pretty safe gamble.

TheDeHymenizer

I'm in way to many right now hahaha, GORO, ELTP, NLST, BLGO, SEUSF. ELTP is really the only one I believe in long term the other ones are "long term holds" but absolute insane gambles.

dbixon

BioLargo (BLGO) really shouldn’t be as low as it is, but unfortunately one stupid pumper has wrecked its credibility by acting like a used car salesman in all his posts. But the company still shows a lot of promise, with some major catalysts due before spring.

TheDeHymenizer

I take a very different approach to penny stocks then this board. I believe there are amazing opportunities that are being largely ignored by the broader market. Instead of waiting for a big move and then getting out I try to find a small number of stocks that have an outsized risk vs reward and pour hundreds to thousands of dollars in them and then hold for years until the rest of the market catches up. So far here's some results from this strategy GORO - down 10% but had about 30% of my initial cost paid off from dividends before the stock collapsed so I may be up on a total basis. Held since 2019 one of my losers BLGO - down like 50% held a bit over a year ELTP - up 50% SEUSF - Up 100%, was up like 400% at one point NLST - Down about 20% The hope is one day I'll be able to cash out on one of these at like $10 or more per share for an absurd % gain and the winners will pay back any losers and then some. I'm pretty confident on all of these (minus GORO) having the potential too do that at some point. Its just a matter of being patient. I know this is a different strat from what you asked but figured it would help add insight into a different method of approaching penny stocks.

dbixon

BLGO I just bought 50k shares last week. They’ve been deep in R&D for several years and now they have products to sell (forever chemical filtration and an improved wound care solution already FDA approved). Their homerun though is energy storage, battery tech. I work in the energy industry and am confident energy storage is the next big commodity play. If their value is realized, this would be a 40x by 2030.

missing-Oz

BLGO

missing-Oz

BLGO

EfficientCommand4368

[AMPG](https://client.schwab.com/SymbolRouting.aspx?symbol=AMPG) AMPLITECH GROUP INC. has treated me very well, and it's never been talked about on here, which is amazing. Also up 15 percent since my last post about it here. https://preview.redd.it/9xmc7doiwvlf1.png?width=1033&format=png&auto=webp&s=c8c65e4ea2f8f09972cc83ed4973d5179f4546df Along with BLGO, ELTP, and ACHV

Fe3Plus

Has anyone looked into BLGO? [https://www.reddit.com/r/BLGO/](https://www.reddit.com/r/BLGO/) What is your take on it?

julian_jakobi

$BLGO Clyra Medical Announcement “We are excited to appoint David Zansitis as Vice President of Clinical Affairs at Clyra Medical Technologies. David’s career spans clinical practice and medical device leadership — from Critical Care and Burn Units in Philadelphia, to the launch of transformative wound care solutions including the Wound Vac, Vashe, and Puracyn. In his new role, David will: ✅ Lead Clyra’s clinical strategy in partnership with our Chief Medical Officer ✅ Build and engage a growing network of key opinion leaders (KOLs) and clinical collaborators ✅ Oversee clinical programs, case series, and investigator-led studies ✅ Collaborate across product, marketing, sales, and regulatory teams to turn clinical evidence into innovation, data-driven messaging, and broader market adoption His expertise in bridging clinical insight with commercialization will be instrumental as we advance our mission of delivering Better Science. Better Outcomes.”

julian_jakobi

Thanks a lot. Glad that you like it and that you agree that a lot of money can be made here. Thanks for mentioning $SCWO again. The PFAS market is that big that most solutions will be needed. Blgo has a destruction device as well. Here’s a quick pro and contra list for BLGO (AEC) and SCWO (Swco) PFAS solutions (perplexity AI) BLGO (AEC) Pros: • Commercially deployed with first paid client. • Over 80% lower lifecycle cost compared to GAC and ion-exchange systems. • Produces minimal PFAS-laden waste. • Modular system, easy scalability for different facility sizes. Cons: • May require pre-treatment for some types of complex influent. • Technology still scaling up for broader, multi-site adoption. • Long-term performance at very large scale yet to be fully demonstrated. SCWO (Swco) Pros: • Destroys >99.99% PFAS, including all types, with no measurable residues. • Used at commercial scale in multiple industries. • Handles concentrated PFAS waste directly without secondary disposal. Cons: • High capital and operational costs for installation and maintenance. • Requires extreme conditions (high temperature, pressure), raising complexity. • Can be unaffordable for smaller municipalities or utilities. BioLargo (BLGO) shows a stronger promise for long-term deployment and investment upside compared to SCWO, mainly due to scalability, operating costs, and business model. BLGO (AEC Solution) • Growth and Investment Potential: BLGO has posted triple-digit revenue growth and is expanding through a capital-efficient licensing and partnership model targeting a broad cleantech market. Their Q2 2025 results show rapid water treatment revenue acceleration (up 152% year over year), and their PFAS technology is highly scalable for municipal, industrial, and potentially global markets. • Long-Term Outlook: BLGO’s cost advantage and modular deployment are seen as ideal for the ongoing global push for PFAS solutions, especially as regulators continue tightening limits and demand grows. • Investment Profile: Analysts and investors highlight BLGO’s diversified growth path in water treatment and energy, historic stock outperformance around major announcements, and a nearly debt-free balance sheet. The company is positioned as an early winner in the PFAS technology race with strong potential for scale and recurring revenue streams. SCWO (Supercritical Water Oxidation) • Market Growth: SCWO as a technology is expected to experience healthy adoption with a forecast CAGR of about 10-11% through 2031. It is essential for sites requiring total PFAS destruction and is getting traction for complex, high-concentration waste markets. • Limitations: Capital intensity, higher operating costs, and site-specific complexity limit its applicability for widespread municipal deployment. Investors see SCWO as valuable for specialized, high-value projects but less attractive as a mass-market opportunity. Market Trends • The PFAS treatment space is growing rapidly, driven by strict regulatory changes, and could reach $1.5B investment in new technologies by 2026, with $400B in total cleanup market size possible. • Investors are advised to focus on companies with scalable, regulatory-compliant, and cost-effective solutions for the largest addressable markets. Integrated, modular, and lower-cost platforms such as BLGO’s AEC are flagged as major long-term opportunities. Conclusion: BLGO’s technology and business model offer a larger, more diversified long-term deployment opportunity, making it the more promising investment in PFAS remediation for mass market impact and sustained growth. SCWO remains important but is more niche for specialized high-concentration use cases.

Necessary-Loss7708

I am a quantumscaper and recently biolargo (BLGO), also have a "for fun" position in a space battery company I am not allowed to mention

Financial_Flight7102

Which part is misinformation? I just think it is not right. That is my opinion. $Clyra$ -> $Film Festival$ -> $JJ$ -> $BLGO$ How much did they pay to your film festival anyways?

julian_jakobi

I trust my DD and it has paid off tremendously on my Exas investment . Not thrilled with the recent price action on BLGO But most my accounts are still in green and I’m taking full advantage of it to strengthen my position. I managed to lower the average of my highest account below .215. Every dip is an opportunity—building a stronger base for the next move up! Staying focused on the fundamentals and long-term growth. When others hesitate, I’m stacking shares at a discount. Greed pays when fear is high- especially when the price went into irrational territory for no real reason ;) -as I tried to lay out above. 🚀 https://preview.redd.it/dp1ea97abzjf1.png?width=654&format=png&auto=webp&s=05ca8cfe1ba9474a7ad4ed1bf78989b134faa5a2

julian_jakobi

Ha! Now that’s the kind of firepower I like to see 🔥 ;) Your handle already got my 100% approval, but finding out we’re basically share-count neighbors seals it! Totally agree. BLGO is sitting way under the radar for now, but that won’t last forever. When the revenue/news wave hits, retail like us will be glad we were early. Go BLGO 🚀

mikeybagofdonuts

I appreciate the info! I currently have RH and Webull accounts, I guess if I’m going to invest in BLGO I’ll have to get an ETrade. Thinking about throwing $1k onto this to see what happens long term. Thanks again!

mikeybagofdonuts

Is there a particular exchange where you’d invest in BLGO? It’s not appearing on Robinhood.

julian_jakobi

Not familiar what Sofi invest is. Ticker symbol is BLGO.

julian_jakobi

Awesome to hear you’re looking closer at BioLargo — I honestly think the deeper you dig, the more you’ll like what you find. Right now they’ve got about $3.5M cash on hand, and they’ve been pretty disciplined with their overhead. Exec comp isn’t a big drag on the burn rate either — most of management are already the largest shareholders, and a lot of their pay is in stock/options (CFO literally only gets paid in stock). That’s real skin in the game. On dilution: you’re right, they’ve leaned on it in the past, but the pace of new issuance has dropped YOY. In preparation of the Clyra launch they had to invest more. The real “end of dilution” will come from execution — and they’re lining up real-world deployments in PFAS cleanup, odor control, energy storage, water treatment, and the focus of the post above - healthcare (wound care). Each of these is a huge market on its own, so if any one of them scales, the financing picture changes a lot. Politics/renewables: yeah, headlines can shift sentiment short-term, but BioLargo’s value is less about chasing subsidies and more about solving trillion-dollar problems. People are always going to need safe water, PFAS-free systems, better batteries, better wound care. These demand drivers don’t go away with the election cycle. And about the spike last year — yeah, that was a crazy ride. At the peak, I was nearly $1M up on paper. But honestly, I didn’t get into this for a quick flip. I’m in it until the full story unfolds. That mindset makes it easier to sit tight through the chop, because I know I’m backing something that can actually make a difference. Like Munger said: “the big money is in the waiting.” That’s been true for me before (EXAS was one I held long before the market caught on), and I’m applying the same patience here. Current price? I don’t see it as discouraging — I see it as a gift. More time to accumulate before the crowd wakes up. And yeah, we’ve got a strong little shareholder community around this. A lot of folks ended up with big positions after doing the deep dive themselves - and we talk BLGO 24/7 - it is great community. It would be great to have you become a part of this!! Please let me know if you have more questions.

Go_BLGO

Real nice DD write-up. This thorough review hits all the burning hot key-points. BLGO is ridiculously undervalued. I wish it had several institutional analysts to follow it. But, that will come sooner than later. But, my bet is that BLGO will show some significant revenue and news before 2026. I am still loading up aggressively on my personal stock holdings, which total just over 4 million shares. Readers will be kicking themselves when this stock breaks $1 per share and they could have had an 80% higher return if they collected shares now. Read this article one more time, there is a lot here to absorb. Go BLGO.

dbixon

Your passion for this investment is very clear and commendable (you’re included in practically every search result for BLGO on Reddit). I am currently on the hunt for a new “swing for the fences” opportunity with about 200k to potentially deploy, and I’m intrigued by BioLargo. A few questions for you: How much cash does BLGO currently have on hand, and what is their burn rate? What percentage of that burn rate is going to executive compensation? What percentage of shares are owned by insiders (not options, but actual shares bought on the open market)? They are certainly not opposed to diluting current shareholders to raise more cash; what indicators exist to suggest that dilution is nearly over? (I see that new-issued shares has declined YOY for the past five years, but am looking more for business catalysts) How does the current political landscape (rolling back renewable focus, precious metal economics, etc.) affect BioLargo’s forecasts? And finally, I see you’ve been championing them hard for several years… when the stock popped to 35c in spring 2024, you must have been very excited. Did you think that was the beginning of greatness? How did you mentally cope with the return back to current levels?

julian_jakobi

Yes, BioLargo, ticker symbol BLGO owns 52% of Clyra Medical.

Dnemis1s

BLGO is the stock in question correct ?

nanocapinvestor

If you just want US-based stocks, look at CBAT, BLGO, EOSE, ADN, ADNWW, and BE. Next time, try searching before posting - I got the tickers by putting your query word for word into an NLP screener: [https://beyondspx.com/?q=companies%20like%20CATL%20that%20have%20promising%20non-lithium%20battery%20technology&date=2025-08-16](https://beyondspx.com/?q=companies%20like%20CATL%20that%20have%20promising%20non-lithium%20battery%20technology&date=2025-08-16)

julian_jakobi

In a recent post, [https://www.reddit.com/r/pennystocks/s/Fj48aRfPPl](https://www.reddit.com/r/pennystocks/s/Fj48aRfPPl) I shared here in detail why I do hold a substantial 1.25% stake in BioLargo $BLGO, a penny stock. (Worth “slightly” less than a million on this dip) Of cause I am a fan of that company, I am extremely bullish and I believe I will get incredibly rich 😉🤷🏼‍♂️ While that post generated around 20k views and a lot of feedback, both positive and critical, many seemed irritated by that much conviction. So I was wondering if others have found their company in the OTC world that they 100% believe in, root for and committed substantial amounts of money to. What’s your rationale behind these commitments, whether it’s the innovative technologies, the growth potential, or the positive impact these companies are making? I’m eager to learn from your experiences and perspectives. Let’s hear about those "all in" OTC investments and let us know why you believe it is worth it and why you believe in their long-term success! BTW - I was not aware that these kinds of posts are not for the man page anymore. Best of luck investing.

Get_rch_or_try_dyin

lol what do you mean? I don’t have any shares of BLGO. But I use their Pooph product because I have 3 cats. Also, my dad has a very large number of shares through a fidelity brokerage account. So I am optimistic. But I definitely don’t have another Reddit account if that’s what you’re saying

julian_jakobi

One of the BLGO accounts 😘 https://preview.redd.it/cmx68iipjhff1.jpeg?width=1290&format=pjpg&auto=webp&s=8f87390689731a479caa2d30de818471e804ee2f

Get_rch_or_try_dyin

What is your average price per share with BLGO? I believe they are going to grow . Honestly, BLGO is better than half the penny stocks that are listed on RH in my opinion.

Sufficient_Fold1517

From what has been shared publicly, I think if Clyra were its own company, it would have a $70-100 million market cap today. With BLGO owning half of it, in my opinion this stock has real potential. Considering it’s trading under $60 million mkt cap today, seems most investors have just lost patience-which is understandable. But I’m adding shares to my kids accounts, as well as mine, as risk of bankruptcy seems gone with Pooph being capable of funding the company if needed.

Get_rch_or_try_dyin

I think it would be a game changer for BLGO if they get listed on RH. Their products actually work great, and they seem like a good company. I can’t believe they aren’t bigger . I use the Pooph spray almost daily for my cats. I hope they continue to grow in each area of their business!

Get_rch_or_try_dyin

I would be very happy if RH added BLGO! Im not familiar with the transition from OTC market to Robinhood . So I don’t know what would be needed

julian_jakobi

For those willing to look deeper, the real story is unfolding quietly beneath the surface. The recent Clyra distribution agreement with a major industry player is a true game-changer—set to amplify the momentum already generated by Pooph. This isn’t just steady progress; it’s a powerful catalyst that could dramatically reshape BioLargo’s future. Despite the overall market’s cautious stance, that very skepticism opens up a rare opportunity. The gap between what’s perceived and what’s actually happening couldn’t be clearer—and savvy investors who spot this early are positioning themselves for substantial upside. In fact, word is circulating about a prominent, well-funded investor with a large following who is actively building a meaningful stake—aiming for 5 to 10 million shares—well ahead of the broader market’s realization. The signs are unmistakable: $BLGO ’s commercial breakthrough is likely just months away, not years. This is the time when strong conviction can truly pay dividends.

julian_jakobi

Good point. Let’s send RH a message that we’d like BLGO to be added.

julian_jakobi

Yes, pretty impressive that they almost stopped the dilution of the parent company. Going to be epic when the medical revenues will hit! "In Q2, Clyra announced a series of sales and distribution agreements covering both U.S. and international markets. These agreements are expected to make Clyra’s products available for purchase by 6,100 hospitals, 6,300 ambulatory surgery centers and 2,200 specialty wound care clinics in the U.S. alone. With unmatched performance claims, it is rewarding to see these innovations now reaching the healthcare settings where they can begin saving lives and improving clinical outcomes in ways not previously possible." $BLGO https://preview.redd.it/4xs1j4vkbpef1.jpeg?width=1290&format=pjpg&auto=webp&s=acff350fb433f67b5c09c5e07cfb664187bb2662

Minute_Plastic_350

BLGO and REPL.. mighty tasty at these levels

CoffeeonMarket

They are two different things - But disclaimer I know Nothing about BLGO. BLGO for whatever reason appears pumped all over the place I don't know why, perhaps bots. I go to a lot of water conference and never heard them mentioned. MTX has close to a $2b market cap BLGO is $60 million PFAS Destruction Oxidation System - I'm having a difficult time understanding the scalability of it beyond a few applications.